DK0424519T3 - Antigeneer fra det transmembranale kappeglycoprotein fra et humant retrovirus af HIV-2-typen samt an tigener, der har et immunologisk slægtskab dermed - Google Patents

Antigeneer fra det transmembranale kappeglycoprotein fra et humant retrovirus af HIV-2-typen samt an tigener, der har et immunologisk slægtskab dermed

Info

Publication number
DK0424519T3
DK0424519T3 DK90908240.6T DK90908240T DK0424519T3 DK 0424519 T3 DK0424519 T3 DK 0424519T3 DK 90908240 T DK90908240 T DK 90908240T DK 0424519 T3 DK0424519 T3 DK 0424519T3
Authority
DK
Denmark
Prior art keywords
antigens
glycoprotein
type
hiv
well
Prior art date
Application number
DK90908240.6T
Other languages
English (en)
Inventor
Bernard Krust
Ara Hovanessian
Anne Laurent
Luc Montagnier
Marie-Anne Rey
Original Assignee
Pasteur Institut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR8906322A external-priority patent/FR2646854A1/fr
Priority claimed from US07/356,459 external-priority patent/US5208321A/en
Application filed by Pasteur Institut filed Critical Pasteur Institut
Application granted granted Critical
Publication of DK0424519T3 publication Critical patent/DK0424519T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
    • C07K16/1063—Lentiviridae, e.g. HIV, FIV, SIV env, e.g. gp41, gp110/120, gp160, V3, PND, CD4 binding site
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK90908240.6T 1989-05-12 1990-05-11 Antigeneer fra det transmembranale kappeglycoprotein fra et humant retrovirus af HIV-2-typen samt an tigener, der har et immunologisk slægtskab dermed DK0424519T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8906322A FR2646854A1 (fr) 1989-05-12 1989-05-12 Antigenes de la glycoproteine transmembranaire d'enveloppe d'un retrovirus humain du type hiv-2 antigenes presentant avec eux une parente immunologique
US07/356,459 US5208321A (en) 1988-06-09 1989-05-25 HIV-2 transmembrane glycoprotein homodimer (GP 80)

Publications (1)

Publication Number Publication Date
DK0424519T3 true DK0424519T3 (da) 1996-05-13

Family

ID=26227325

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90908240.6T DK0424519T3 (da) 1989-05-12 1990-05-11 Antigeneer fra det transmembranale kappeglycoprotein fra et humant retrovirus af HIV-2-typen samt an tigener, der har et immunologisk slægtskab dermed

Country Status (11)

Country Link
EP (1) EP0424519B1 (da)
JP (5) JP3534746B2 (da)
AT (1) ATE136789T1 (da)
CA (1) CA2032505C (da)
DE (1) DE69026569T2 (da)
DK (1) DK0424519T3 (da)
ES (1) ES2085908T3 (da)
HK (1) HK219796A (da)
OA (1) OA09634A (da)
SG (1) SG48125A1 (da)
WO (1) WO1990013314A2 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5256561A (en) * 1991-12-20 1993-10-26 Abbott Laboratories Monoclonal antibody to HIV-2 and uses thereof
FR2692898B1 (fr) * 1992-06-30 1995-06-02 Centre Nat Rech Scient Procédé d'obtention de protéines membranaires, et utilisation de ces protéines dans un but de diagnostic ou de vaccination.
JP2013040148A (ja) * 2011-08-19 2013-02-28 Asahi Kasei Corp シアリルオリゴ糖ペプチド固定化ビーズ

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0239425B1 (fr) * 1986-01-22 1989-11-02 Institut Pasteur Rétrovirus du type HIV-2 susceptible de provoquer le SIDA, et ses constituants antigéniques et nucléiques
EP0269520A3 (fr) * 1986-11-21 1988-08-24 Institut Pasteur Rétrovirus du type HIV-2 susceptible de provoquer le sida, et ses constituants antigéniques et nucléiques
EP0283327B1 (fr) * 1987-01-16 1997-06-25 Institut Pasteur Peptides ayant des propriétés immunologiques de HIV-2
FR2620030B1 (fr) * 1987-09-07 1990-03-23 Transgene Sa Vecteur d'expression des proteines du virus hiv-2, un agent causal du sida, culture cellulaire infectee ou transformee par ce vecteur, proteines obtenues, vaccin et anticorps obtenus

Also Published As

Publication number Publication date
JP2008156350A (ja) 2008-07-10
JP2003146999A (ja) 2003-05-21
EP0424519A1 (fr) 1991-05-02
SG48125A1 (en) 1998-04-17
JP3833681B2 (ja) 2006-10-18
JP2006213702A (ja) 2006-08-17
DE69026569T2 (de) 1996-09-05
JP4174591B2 (ja) 2008-11-05
HK219796A (en) 1997-01-03
CA2032505C (fr) 2001-07-10
ES2085908T3 (es) 1996-06-16
JP2005170949A (ja) 2005-06-30
WO1990013314A3 (fr) 1990-12-27
WO1990013314A2 (fr) 1990-11-15
CA2032505A1 (fr) 1990-11-13
DE69026569D1 (de) 1996-05-23
JP3534746B2 (ja) 2004-06-07
OA09634A (fr) 1993-04-30
JPH03506042A (ja) 1991-12-26
EP0424519B1 (fr) 1996-04-17
ATE136789T1 (de) 1996-05-15
JP4423374B2 (ja) 2010-03-03

Similar Documents

Publication Publication Date Title
MY103182A (en) Vaccines against acquired immune deficiency syndrome.
ATE109795T1 (de) Htlv-iii umhüllende peptiden.
FI940681A0 (fi) Menetelmä ja koostumuksia, jotka liittyvät Moraxella catarrhalisin käyttökelpoisiin antigeeneihin
CA2121241A1 (en) Porcine reproductive respiratory syndrome vaccine and diagnostic
DE3855947D1 (de) Peptide mit den immunologischen Eigenschaften von HIV-2
CA2111325A1 (en) Detection of mammalian immunodeficiency viruses
DK0424519T3 (da) Antigeneer fra det transmembranale kappeglycoprotein fra et humant retrovirus af HIV-2-typen samt an tigener, der har et immunologisk slægtskab dermed
ATE159983T1 (de) Monoklonaler antikörper gegen htlv-iii (stamm mn)
ES2083388T3 (es) Anticuerpos dirigidos contra proteinas y glucoproteinas del retrovirus vih-2 eho - aplicaciones para el diagnostico.
ATE224202T1 (de) Cloniertes protein der äusseren membran von leptospira
PT90800A (pt) Processo para a preparacao de antigenios precursores das glicoproteinas de involucro de um retrovirus humano hiv-2 e de antigenios que apresentem uma analogia imonulogiga com estes ultimos e sua aplicacao ao diagnostico